MENLO PARK, Calif. and SINGAPORE, Sept. 13, 2022 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative ...
Sept 28 (Reuters) - Aslan Pharmaceuticals Ltd: * ASLAN PHARMACEUTICALS PRESENTS NEW DATA ON EBLASAKIMAB IN TWO LATE-BREAKING E-POSTERS AT 51ST ANNUAL EUROPEAN SOCIETY FOR DERMATOLOGICAL RESEARCH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results